Eagle Pointome Valuation
EICB Stock | 25.04 0.01 0.04% |
At this time, the firm appears to be overvalued. Eagle Pointome shows a prevailing Real Value of USD20.88 per share. The current price of the firm is USD25.04. Our model computes the value of Eagle Pointome from reviewing the firm fundamentals such as Profit Margin of 0.27 %, number of shares shorted of 46, and Current Valuation of 764.39 M as well as analyzing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Eagle Pointome's price fluctuation is very steady at this time. Calculation of the real value of Eagle Pointome is based on 3 months time horizon. Increasing Eagle Pointome's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Eagle Pointome is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Eagle Stock. However, Eagle Pointome's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. Historical | Market 25.04 | Real 20.88 | Hype 25.04 | Naive 25.09 |
The real value of Eagle Stock, also known as its intrinsic value, is the underlying worth of Eagle Pointome Company, which is reflected in its stock price. It is based on Eagle Pointome's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Eagle Pointome's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Eagle Pointome helps investors to forecast how Eagle stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Eagle Pointome more accurately as focusing exclusively on Eagle Pointome's fundamentals will not take into account other important factors: Eagle Pointome Total Value Analysis
Eagle Pointome is currently forecasted to have valuation of 764.39 M with market capitalization of 764.39 M, debt of 138.55 M, and cash on hands of . Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Eagle Pointome fundamentals before making equity appraisal based on enterprise value of the companyTakeover Price | Market Cap | Debt Obligations | Cash |
764.39 M | 764.39 M | 138.55 M |
Eagle Pointome Investor Information
The company last dividend was issued on the 11th of July 2025. Based on the measurements of operating efficiency obtained from Eagle Pointome's historical financial statements, Eagle Pointome is not in a good financial situation at this time. It has a very high probability of going through financial hardship in August.Eagle Pointome Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Eagle Pointome has an asset utilization ratio of 10.03 percent. This suggests that the Company is making USD0.1 for each dollar of assets. An increasing asset utilization means that Eagle Pointome is more efficient with each dollar of assets it utilizes for everyday operations.Eagle Pointome Profitability Analysis
The company reported the previous year's revenue of 45.68 M. Net Income was 41.55 M with profit before overhead, payroll, taxes, and interest of 51.22 M.Eagle Pointome Past Distributions to stockholders
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Eagle Pointome's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Eagle Pointome and how it compares across the competition.
About Eagle Pointome Valuation
The stock valuation mechanism determines Eagle Pointome's current worth on a weekly basis. Our valuation model uses a comparative analysis of Eagle Pointome. We calculate exposure to Eagle Pointome's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Eagle Pointome's related companies. Eagle Pointome's stock price is the clearest measure of market expectations about its performance. Without stock valuation, investors cannot independently discern whether Eagle Pointome's value is low or high relative to the company's performance and growth projections. Determining the market value of Eagle Pointome can be done in different ways, such as multiplying its stock price by its outstanding shares.A single share of Eagle Pointome represents a small ownership stake in the entity. As a stockholder of Eagle, your percentage of company ownership is determined by dividing the number of shares you own by the total number of shares outstanding and then multiplying that amount by 100. Owning stock in a company generally confers both corporate voting rights and income from any dividends paid to the stock owner.
Eagle Pointome Dividends Analysis For Valuation
There are various types of dividends Eagle Pointome can pay to its shareholders, and the actual value of the dividend is determined on a per-share basis. It is to be paid equally to all of Eagle shareholders on a specific date, known as the payable date. The cash dividend is the most common type of dividend payment - it is the payment of actual cash from Eagle Pointome directly to its shareholders. There are other types of dividends that companies can issue, such as stock dividends or asset dividends. When Eagle pays a dividend, it has no impact on its enterprise value. It does, however, lowers the Equity Value of Eagle Pointome by the value of the dividends paid out.
Eagle Pointome Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
Common Stock Shares Outstanding | 14.8 M | |
Quarterly Earnings Growth Y O Y | 0.036 | |
Forward Annual Dividend Rate | 1.94 |
Complementary Tools for Eagle Stock analysis
When running Eagle Pointome's price analysis, check to measure Eagle Pointome's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eagle Pointome is operating at the current time. Most of Eagle Pointome's value examination focuses on studying past and present price action to predict the probability of Eagle Pointome's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eagle Pointome's price. Additionally, you may evaluate how the addition of Eagle Pointome to your portfolios can decrease your overall portfolio volatility.
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |